BMX-IN-1   Click here for help

GtoPdb Ligand ID: 9269

Synonyms: Example 1-14 [ WO2014063054]
Compound class: Synthetic organic
Comment: BMX-IN-1 is a selective and irreversible inhibitor (8nM IC50) which covalently modifies Cys496 in the BMX kinase and exhibits antiproliferation efficacy against prostate cancer cells [2]. This compound has a Probe Portal entry SGC BMX-IN-1. A series of analogues of this structure with activity data are disclosed in a 2014 patent [1]
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 2
Rotatable bonds 7
Topological polar surface area 118.02
Molecular weight 524.15
XLogP 5.26
No. Lipinski's rules broken 1
Click here for help
Canonical SMILES C=CC(=O)Nc1cc(ccc1C)n1c(=O)ccc2c1c1cc(ccc1nc2)c1ccc(cc1)NS(=O)(=O)C
Isomeric SMILES C=CC(=O)Nc1cc(ccc1C)n1c(=O)ccc2c1c1cc(ccc1nc2)c1ccc(cc1)NS(=O)(=O)C
InChI InChI=1S/C29H24N4O4S/c1-4-27(34)31-26-16-23(12-5-18(26)2)33-28(35)14-9-21-17-30-25-13-8-20(15-24(25)29(21)33)19-6-10-22(11-7-19)32-38(3,36)37/h4-17,32H,1H2,2-3H3,(H,31,34)
1. Grey N et al.. (2014)
Bone marrow on x chromosome kinase (bmx) inhibitors and uses thereof.
Patent number: WO2014063054. Assignee: Dana-Farber Institute. Priority date: 19/10/2012. Publication date: 19/07/2014.
2. Liu F, Zhang X, Weisberg E, Chen S, Hur W, Wu H, Zhao Z, Wang W, Mao M, Cai C et al.. (2013)
Discovery of a selective irreversible BMX inhibitor for prostate cancer.
ACS Chem Biol, 8 (7): 1423-8. [PMID:23594111]